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Mutations in the methyl-CpG binding protein 2 gene, Mecp2, affect primarily the brain and lead to a wide range of neuropsychiatric
disorders, most commonly Rett syndrome (RTT). Although the neuropathology of RTT is well understood, the cellular and molecular
mechanism(s), which lead to the disease initiation andprogression, has yet to be elucidated. RTTwas initially attributed only to neuronal
dysfunction, but our recent studies and those of others show that RTT is not exclusively neuronal but rather also involves interactions
between neurons and glia. Importantly, studies have shown that MeCP2-restored astrocytes and microglia are able to attenuate the
disease progression in otherwise MeCP2-null mice. Here we show that another type of glia, oligodendrocytes, and their progenitors are
also involved inmanifestation of specific RTT symptoms.Mice that lostMeCP2 specifically in the oligodendrocyte lineage cells, although
overall normal, were more active and developed severe hindlimb clasping phenotypes. Inversely, restoration of MeCP2 in oligodendro-
cyte lineage cells, in otherwise MeCP2-null mice, although only mildly prolonging their lifespan, significantly improved the locomotor
deficits and hindlimb clasping phenotype, both in male and female mice, and fully restored the body weight in male mice. Finally, we
found that the level of somemyelin-related proteins was impaired in the MeCP2-null mice. Expression of MeCP2 in oligodendrocytes of
thesemice only partially restored their expression, suggesting that there is a non–cell-autonomous effect by other cell types in the brains
on the expression of myelin-related proteins in oligodendrocytes.
Introduction
Rett syndrome (RTT) is an autism spectrum disorder caused by
sporadic mutations in the X-chromosome-linked gene methyl-
CpG binding protein 2 (Mecp2) (Amir et al., 1999). Girls born
with RTT attain normal developmental milestones; however, at
12–18months of age, they regress, losing speech andmotor skills
and suffering other severe problems, including mental retarda-
tion, respiratory abnormalities, epileptic seizures, and overall re-
tarded growth (Hagberg, 2002). Several mouse models with
different germlinemutations inMecp2 have been generated, each
of which recapitulatesmany characteristic features of RTT (Chen
et al., 2001; Guy et al., 2001; Shahbazian et al., 2002). Impor-
tantly, conditional knock-out (k/o) of Mecp2 specifically in the
brain results in a similar RTT phenotype (Chen et al., 2001),
suggesting that RTT is caused primarily by dysfunction ofMeCP2
in cells of the CNS.
Previously, RTT was attributed solely to neuronal dysfunc-
tion. However, studies by ourselves and others have shown that
mutant glia, including astrocytes and microglia, are an integral
part of manifestation of RTT, affecting neuronal structure and
function (Ballas et al., 2009; Maezawa and Jin, 2010; Lioy et al.,
2011; Derecki et al., 2012). Our recent studies further show that,
like neurons, astrocytes ofMeCP2-null mice also exhibit reduced
process complexity (Nguyen et al., 2012). Importantly, reexpres-
sion ofMeCP2 specifically in astrocytes ormicroglia of RTTmice
significantly improves motor activities and behaviors, as well as
prolongs lifespan to nearly normal (Lioy et al., 2011; Derecki et
al., 2012).
Among glial cells, oligodendrocyte lineage cells, including oli-
godendrocyte precursor cells (OPCs, also known as NG2 cells)
and oligodendrocytes, are active participants in neural networks.
In addition to serving as progenitors for oligodendrocytes, OPCs
also receive synaptic inputs from neurons (Bergles et al., 2010),
and oligodendrocytes, the myelinating cells in the brain, play
critical roles in propagation of neuronal signaling (Baumann and
Pham-Dinh, 2001). Despite their important role in brain func-
tion, the critical question of whether oligodendrocyte lineage
cells contribute to RTT neuropathology has not been addressed.
Here we show that mice lacking MeCP2 only in oligodendro-
cyte lineage cells, although overtly normal, are more active com-
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pared with their control siblings and develop a severe hindlimb
clasping phenotype, indicative of a general neurological malaise.
In reciprocal studies, expression ofMeCP2 solely in oligodendro-
cyte lineage cells resulted in significant improvement of certain
RTT symptoms, including full restoration of body weight inmale
mice, and significant improvement of hindlimb clasping pheno-
type and motor activity deficits in both male and female mice.
Lifespan, however, was onlymildly prolonged, distinguishing the
role of oligodendrocytes and astrocytes in this parameter. Finally,
we identified somemyelin-related proteins whose expressionwas
impaired in brains of MeCP2-null mice. While the reduced ex-
pression of myelin binding protein (MBP) was only partially re-
stored upon expression of MeCP2 in oligodendrocyte lineage
cells, the impaired expression of the myelin proteolipid protein
(PLP) remained unchanged, suggesting that there is a non–cell-
autonomous effect by other cell types in the brain on the expres-
sion of these proteins in the oligodendrocytes of RTT mice.
Materials andMethods
Animals
All animal studies were approved by the Institutional Animal Care and
Use Committees at Stony Brook University and were in line with the
guidelines established by the National Institute of Health.
Mecp2Stop/y (Guy et al., 2007) (B6.129P2-Mecp2tm2Bird/J) transgenic
mice were obtained fromThe Jackson Laboratory. TheMecp2loxJ/y (Chen
et al., 2001) (B6;129S4-Mecp2tm1Jae/Mmcd) transgenic mice were ob-
tained from MMRRC and NG2Cre (Ng2CreBAC) (Komitova et al.,
2009) transgenic mice were provided by Dr. Colognato (Stony Brook
University). To generate the double-transgenic Mecp2loxJ/y/NG2Cre
males and all their control littermates (wild-type [WT], NG2Cre, and
Mecp2loxJ/y), we crossed female mice heterozygous for the Mecp2-lox
allele (Mecp2loxJ/) with male mice heterozygous for the NG2Cre trans-
gene. Similar strategy was used to generate the Mecp2Stop/y/NG2Cre or
Mecp2Stop//NG2Cre and the necessary control mice (WT,NG2Cre, and
Mecp2Stop/y orMecp2Stop/). Only F1 mouse generation was used in this
study. Mice were genotyped by tail biopsies, and the flox and Cre se-
quences were identified by PCR using the following sets of primers and
according to the recommendation from The Jackson Laboratory: for
Mecp2loxJ allele, forward, 5-CAC CAC AGA AGT ACT ATG ATC-3;
reverse, 5-CTAGGTAAGAGCTCTTGTTGA-3. ForMecp2Stop allele,
forward, 5-AAC AGT GCC AGC TGC TCT TC-3; mutant reverse,
5-GCC AGA GGC CAC TTG TGT AG-3; WT reverse, 5-CTG TAT
CCT TGG GTC AAG CTG-3. For the NG2Cre allele, forward, 5-CCG
TAC ACC AAA ATT TGC C-3; reverse, 5-ATC GCG AAC ATC TTC
AGG-3. When necessary, female and male were distinguished by using
Y-chromosome primers designated ZFY, forward, 5-AAG ATA AGC
TTA CAT AAT CAC ATG GA-3; reverse, 5-CCT ATG AAA TCC TTT
GCT GCA CAT GT-3.
Phenotypic scoring
Male and femalemice were scored weekly or biweekly, respectively.Mice
were removed from their home cage and placed onto a bench, at the same
time during the day when possible. The scoring was performed essen-
tially as we previously described (Nguyen et al., 2012). Each of the five
symptoms, includingmobility, gait, hindlimb clasping, tremor, and gen-
eral condition was scored as 0 (symptom absent), 1 (symptom present),
or 2 (symptom severe).
Behavioral assays
For all behavioral studies, the observer was blinded to genotype.
Digiscan activity monitor. The mouse was placed in the center of an
empty rat cage (44 cm 21 cm) situated inside anOpto-Varimex-Minor
animal activity meter (Columbus Instruments). The 15  15 infrared
beams running in the x-y coordinates and 2 cm above the base of the
machine recorded beambreaks associatedwith ambulatory activity (con-
secutive beam breaks) and total activity (all beam interruptions) during
the 20 min observation period. Supported motor movements or full
rearing (vertical activity) were defined as an animal using its upper and
lower limbs to reach up the side of a cage and hold its body up.
Rotarod. Mice were tested on a Medical Associates (model ENV-
575M) Rotorod and ran by the “rotarod” controlled by a Dell Optiplex
with aWindows 98 operating platform. The apparatus was amechanized
30-cm-long rod divided into five 6 cm sections by 4 plastic white discs.
The speed of rotation increased from 4 to 40 rpm through the course of 5
min session. The latency in seconds to drop off the rotarod was the main
dependent measure of motor competence. Each mouse was tested for
three consecutive trials with a 10 min rest between each session.
Wire hang test. The mice were placed on a 44-cm-long stainless steel
wire suspended 54 cm off the ground by two wooden posts so that only
their front paws contact the wire. The latency to fall onto a foam pad
below the apparatus was recorded. The maximum hang time was 60 s
before removal. Each mouse was tested on three consecutive trials with-
out resting.
Open-field activity. Mecp2loxJ/y/NG2Cre and Mecp2loxJ/y mice were
tested in this apparatus, which was square and made of wood covered
with vinyl (60 60 cm), and the walls surrounding it were 25 cm high.
The arena was divided in 16 squares (10 10 cm). The mice were left to
explore the open arena for 10min. The trial was videotaped. The number
of times the mice crossed a line was counted.
Light-dark box test. The light/dark box (43  21  21 cm) was made
from a translucent Plexiglas box and consisted of two chambers con-
nected by an opening (5 5 cm) located at the floor level in the center of
the dividing wall. The small chamber (dark compartment) (14 21 cm)
was painted black, and the large chamber (light compartment) (29 21
cm)was left translucent.Micewere placed in the dark chamber facing the
opening immediately covered by a dark lid and were allowed to explore
the apparatus for 5 min. The latency to exit the dark chamber, the length
of time spent in the light side of the box, and the number of transition
(number of time the animal passed in and out the light and dark cham-
bers) were recorded.
Western blot analysis
Whole-brain tissues were homogenized in a Dounce homogenizer with
the loose pestle in high-salt lysis buffer containing 20mMHEPES, pH7.9,
1.5 mMMgCl2, 0.2 mM EDTA, 420 mMNaCl, 0.5 mMDTT, 20% glycerol
and protease inhibitors (Roche). Western blotting was performed as de-
scribed previously (Ballas et al., 2009). The primary antibodies used are
as follows: chicken anti-MeCP2 antibody (a generous gift from Dr. J.M.
LaSalle, University of California Davis) (1:10,000) or a mouse anti-
MeCP2 (Sigma) (1:2000), mouse anti-MBP (Covance) (1:1000), rabbit
anti-PLP (Santa Cruz Biotechnology) (1:5000), mouse anti-CNPase
(Sigma) (1:5000), and rabbit anti-myelin oligodendrocyte glycoprotein
(MOG; Epitomics) (1:1000). Rabbit anti- actin (Abcam) (1:5000) was
used for loading control. The secondary antibodies used were IRDye800
or IRDye700-conjugated (LI-COR Biosciences) (1:10,000). Membranes
were scanned using the Odyssey-Infrared Imaging System (LI-COR Bio-
sciences), and the intensities of the bands of interest were determined
from the captured images using the Odyssey imaging software.
Immunohistochemistry
Mice were fixed by transcardial perfusion with PBS-buffered 4% para-
formaldehyde as described previously (Ballas et al., 2009). Brains were
removed and postfixed overnight with PBS-buffered 4% paraformalde-
hyde at 4°C. The fixed tissue was cryoprotected with 30% sucrose in PBS
buffer and frozen in optimal cutting medium (Neg50, Richard-Allan
Scientific). Coronal sections were obtained by sectioning the tissue on a
HM505EMicromCryostat (Cryostat Industries) at 40m thickness and
preserved at 20°C in PBS-buffered 50% glycerol until analyzed. The
sections were immunostained using rabbit anti-MeCP2 antibody (a gener-
ousgift fromDr.M.E.Greenberg,HarvardMedical School) (1:500), chicken
anti-GFAP (Millipore Bioscience Research Reagents) (1:500), mouse anti-
NeuN (Millipore Bioscience Research Reagents) (1:150), guinea pig anti-
NG2 (a generous gift from Dr. W.B. Stallcup, Burnham Institute), mouse
anti-CC1 (Calbiochem) (1:100), mouse anti-S100 (Sigma) (1:2000), and
mouseanti-MBP(Covance) (1:250), followedby incubationwith theappro-
priate secondary antibodies conjugated to cyanine (Jackson ImmunoRe-
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search Laboratories). MeCP2 immunostaining was enhanced using biotin
streptavidin–conjugated secondary antibodies. Images were collected on a
Zeiss confocal laser scanning LSM 510microscope.
Statistics
To compare the two genotypes within each treatment or time point, t test
or Mann–Whitney test was used. One-way ANOVA or two-way
repeated-measures ANOVA was used for multiple-group comparisons
and were followed byHolm-Sidak post hoc testing in all cases. The signif-
icance level of themain effect and interaction are presented following the
description of each particular test in the figure legends. A minimum p
value of 0.05 was accepted as statistically significant throughout. Data are
presented as mean SEM.
Results
MeCP2 is depleted specifically in the oligodendrocyte lineage
cells of theMecp2loxJ/y/NG2Cremouse brain
Previously, we showed that MeCP2 is present in all WT glia,
includingOPCs and their differentiated oligodendrocytes, in pri-
mary cultures as well as in postnatal mouse brain (Ballas et al.,
2009). We confirmed the presence of MeCP2 in OPCs (NG2
Figure1. MeCP2protein is specifically depleted fromtheoligodendrocyte lineage cells in brains ofMecp2loxJ/y/NG2Cre mice.A, Representative images of brain sections ofWTandRTT (Mecp2J. -/y)
(Chen et al., 2001) male mice coimmunolabeled for MeCP2 (green) and NG2 (red). DAPI (blue) represents nuclear staining. MeCP2 (green) is expressed in OPCs (NG2, red) in the hippocampus of
WTmiceandabsent inRTTmice. Scalebars, 20m.B, Representative imagesofbrain sections showing thepresenceofMeCP2 inall cell types in thebrainofNG2Cremalemiceand its specific absence
in the oligodendrocyte lineage cells (NG2 and CC1 cells) in the brain ofMeCP2loxJ/y/NG2Cremale mice. Sections were coimmunolabeled for MeCP2 (green) and neuronal marker (NeuN, red) in
the dentate gyrus area, MeCP2, and astrocytic (GFAP, red) or OPCs (NG2, red) markers in the hippocampus, andMeCP2 andmature oligodendrocytic marker (CC1, red) in the corpus callosum. DAPI
(blue) represents nuclear staining. Scale bars, 20m. Arrows indicate colocalization or absence of MeCP2 in GFAP, NG2, or CC1-positive cells.
18766 • J. Neurosci., November 27, 2013 • 33(48):18764–18774 Nguyen et al. • Oligodendrocytes Contribute to Rett Syndrome
cells) of theWT brain and showed that it is absent in OPCs of the
RTT mouse brain (Fig. 1A). To analyze the role that MeCP2
might play in oligodendrocyte lineage cells, we generated an
NG2-inducible Mecp2 k/o mouse model by crossing the trans-
genic mouse line NG2Cre (Komitova et al., 2009) with a mouse
line carrying floxed Mecp2 allele (Mecp2loxJ) (Chen et al., 2001).
We examined male progenies harboring the NG2Cre and the
Mecp2loxJ alleles (Mecp2loxJ/y/NG2Cre) for the specificity of
Mecp2-lox excision by the Cre recombinase in the OPCs and the
differentiated oligodendrocytes. Immunostaining for MeCP2
and cell-specific markers confirmed the presence ofMeCP2 in all
cell types in the brain of the controlNG2Cremice and its specific
absence in OPCs and oligodendrocytes in the brain of Mecp2loxJ/y/
NG2Cremice (Fig. 1B). Specifically, MeCP2 was undetectable in
most OPCs in different brain areas (3–11% NG2/MeCP2
cells) of Mecp2loxJ/y/NG2Cre mice but remained present in neu-
rons (93–98% NeuN/MeCP2) and astrocytes (90–96%
GFAP/Mecp2 cells) (Fig. 1B; Table 1). Furthermore, only 8%
of mature oligodendrocytes (CC1) expressed MeCP2 in the
corpus callosum of these mice (Fig. 1B; Table 1). The specific
excision of theMecp2-lox cassette byNG2Cre in oligodendrocyte
lineage cells coincides with the published fate analysis of NG2
cells in the NG2Cre/ROSA26R double-transgenic mice (Komi-
tova et al., 2009).
The loss of MeCP2 in oligodendrocyte lineage cells results in
selective RTT-like behavioral deficits
We examined whether theMecp2loxJ/y/NG2Cremice develop any
overt RTT-like phenotypes compared with MeCP2-null mice
bearing the same mutation (Mecp2J.-/y) (Chen et al., 2001). For
this, animals wereweekly scored following the observational phe-
notypic scoring system (0–10) described previously (Guy et al.,
2007; Nguyen et al., 2012), for five typical RTT phenotypes: mo-
bility, gait, hindlimb clasping, tremors, and general condition. As
previously published (Chen et al., 2001), the MeCP2-null mice
developed overt RTT phenotypes beginning at 4–5 weeks of age,
which worsen with time, reaching a score of 6–10 between 9 and
15 weeks of age (Fig. 2A), and died prematurely (Fig. 2B). In
contrast, Mecp2loxJ/y/NG2Cre male mice had a normal lifespan;
however, they developed a mild RTT-like phenotype starting at
10 weeks of age and progressing to an aggregate score of 2 at 20
weeks of age (Fig. 2C). The scores of all control littermate mice,
includingWT,NG2Cre, andMecp2loxJmale mice, were 0 or close
to 0 at all time points (Fig. 2C). Specifically, the Mecp2loxJ/y/
NG2Cre mice exhibited dull fur, and some of them presented
piloerection. A low percentage (20%) of theMecp2loxJ/y control
mice showed amild hindlimb clasping phenotype (Fig. 2D) likely
because of the hypomorphic Mecp2-lox allele. Indeed, quantita-
tiveWestern blot analysis and immunostaining of different brain
areas showed slightly reduced MeCP2 expression in Mecp2loxJ/y
mice relative to their WT littermates (Fig. 3A,B). Nonetheless, a
significantly higher percentage (60%) of the Mecp2loxJ/y/
NG2Cre mice had hindlimb clasping phenotype compared with
their controlMecp2loxJ/ y littermates, which was also more severe
and involved more frequent clasping of both hindlimbs (Fig.
2D,E).
We then examined the behavioral performance of the
Mecp2loxJ/y/NG2Cremice at 32 weeks of age, when their aggregate
symptom score had reached a plateau of2 (Fig. 2C). Our data
show that these mice had no deficits in motor coordination, grip
strength, or anxiety-like behaviors compared with their control
littermates, as assessed by the rotarod, wire hang, and light/dark
box tests, respectively (Fig. 2F–H). Themotor skill learning of the
Mecp2loxJ/y/NG2Cre mice was not affected either as their perfor-
mance in the rotarod significantly increased between the first and
the third trials (Fig. 2F). As expected, because of the hypomor-
phic allele (Fig. 3), in the digiscan test,Mecp2loxJ/y mice were less
active than the WT or NG2Cre control littermates (Fig. 2 I, J).
Surprisingly, however, Mecp2loxJ/y/NG2Cre mice showed an in-
crease in total and vertical activity compared with theMecp2loxJ/y
mice, reaching a level close to that of WT andNG2Cremice (Fig.
2 I, J). This relative greater activity level was confirmed in an open
field test in which the Mecp2loxJ/y/NG2Cre mice crossed signifi-
cantly more lines (70% and 100% more lines in day 1 and day 2
trials) than theMecp2loxJ/y mice in a 10 min session (Fig. 2K).
MeCP2 expression is restored specifically in the
oligodendrocyte lineage cells of theMecp2Stop/y/NG2Cre
mouse brain
As the absence of MeCP2 just in oligodendrocyte lineage cells led
to partial RTT phenotypes, we asked whether normal MeCP2
expression in oligodendrocyte lineage cells in otherwise MeCP2-
null mice, could rescue, at least in part, RTT-like symptoms. For
this, we crossed heterozygous NG2Cremale mice with heterozy-
gous female mice containing a Cre-excisable transcriptional Stop
sequence in the endogenous Mecp2 gene (Mecp2Stop/) (Guy et
al., 2007), to generatemale progeny harboring theNG2Cre trans-
gene and theMecp2Stop allele (Mecp2Stop/y/NG2Cre), and the con-
trol littermates, including WT, NG2Cre, and Mecp2Stop/y male
mice. We first confirmed by immunostaining for MeCP2
and cell-specific markers that neurons (NeuN), astrocytes
(GFAP), OPCs (NG2), andmature oligodendrocytes (CC1)
in the brain of Mecp2Stop/y mice were deficient for MeCP2 (Fig.
4A). We then examined whether MeCP2 was specifically ex-
pressed in the oligodendrocyte lineage cells in the brain of
Mecp2Stop/y/NG2Cremice. Our data show that 75–85% of OPCs
(NG2) in different areas of the brain, including cortex, hip-
pocampus, and striatum, and 90% of the mature oligodendro-
cytes (CC1) in the corpus callosum express MeCP2 (Fig. 4B;
Table 2). The expression of MeCP2 protein is specific to the
oligodendrocyte lineage cells as indicated by the absence of
MeCP2 in the majority of the neurons (0.5%–4.3% NeuN/
MeCP2) and astrocytes (1%–2.2% GFAP/MeCP2) of dif-
ferent brain areas (Fig. 4B; Table 2). We were cognizant of
previous observation that a subset of protoplasmic astrocytes,
whichwereGFAP-negative but S100-positive in the ventral area
of the cortex, were derived from cells expressing NG2Cre (Zhu et
al., 2008). Therefore, we also counted cells that are S100/
MeCP2 in this specific area; whereasmost S100 cells expressed
MeCP2 in theWTmice, only 11–12% reexpressedMeCP2 in the
Mecp2Stop/y/NG2Cremice (Fig. 4B, bottom; Table 2).
Table 1. Specificity and recombination efficiency in different areas ofMecp2loxJ/y/
NG2Cremouse braina
MeCP2loxJ/y/NG2Cre
%MeCP2/
NG2
%MeCP2/
CC1
%MeCP2/
NeuN
%MeCP2/
GFAP
Cortex 9.6 (99) 7.7 (246) 93.3 (932) 96.4 (102)
Hippocampus 11.3 (123) 6.5 (170) 94.7 (894) 92.8 (98)
Thalamus 6.6 (98) 6.7 (388) 97.4 (894) 89.9 (335)
Hypothalamus 9.3 (113) 2.9 (614) 97.7 (891) 91.1 (417)
Cerebellum 10.2 (108) 4.9 (618) 98.1 (915) 96.4 (259)
Hindbrain 3.5 (114) 9.1 (460) 95.9 (821) 92.6 (286)
Corpus callosum — 8.3 (215) — —
aValues in parentheses indicate total number of cells.
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The expression of MeCP2 solely in oligodendrocyte lineage
cells partially restores some of the overt RTT-like phenotypes
in male and female RTTmice
We first analyzed whether normal MeCP2 expression in oligo-
dendrocyte lineage cells could rescue some of the classical RTT-
like phenotypes previously described for the Mecp2Stop/y mice
(Guy et al., 2007) as well as other MeCP2-null mice (Chen et al.,
2001;Guy et al., 2001) (Fig. 2A,B) or delayed their onset. For this,
Mecp2Stop/y/NG2Cre mice and age-matched control littermates
were weekly weighted and scored following the observational
phenotypic scoring system (0–10) described above. Although
WTandNG2Cremice had no symptoms, as expected,Mecp2Stop/y
mice showed severe progression of aggregate symptom scores
followed by lethality, with 50% survival at 13 weeks of age (Fig.
5A,C). Mecp2Stop/y/NG2Cre progeny showed similar kinetics of
symptom progression as theMecp2Stop/ymice (Fig. 5A); however,
a significantly lower percentage of these mice developed the
hindlimb clasping phenotype (40%) compared with the
Mecp2Stop/y mice (65%) (Fig. 5B). In addition, the lifespan of
Mecp2Stop/y/NG2Cremice was prolonged by3 weeks compared
with theMecp2Stop /y mice with a 50% survival at 16 weeks of age
(Fig. 5C). Furthermore, whereas the Mecp2Stop /y mice were un-
derweight, the body weight of the Mecp2Stop/y/NG2Cre mice was
fully restored to the level of the control WT and NG2Cre litter-
mate male mice (Fig. 5D). These data show that the expression of
MeCP2 just in oligodendrocyte lineage cells can partially or fully
restore some of the overt RTT-like phenotypes, although the
shortened lifespan was only mildly improved.
In humans, RTT manifests predominantly in girls. There-
fore, we also analyzed the effect of the restoration of MeCP2
Figure 2. The loss of MeCP2 expression only in the oligodendrocyte lineage cells results in hindlimb clasping and increased motor activity phenotypes. A, B, Phenotypic scores (A) and
Kaplan–Meier survival time course (B) of the MeCP2-null mice (Mecp2J.-/y) compared with WT control mice. C, D, Phenotypic scores and percentage of hindlimb clasping, respectively, of the
Mecp2loxJ/y/NG2Cre and the indicated littermate control male mice. E, Images illustrating the hindlimb clasping phenotype of theMecp2loxJ/y/NG2Cremouse compared with the controlMecp2loxJ/y
mouse. F, Rotarod test. G, Wire-hang test. H, Light/dark box test. I, J, Total and vertical supported activity test in digiscan activity monitor, respectively. K, Total activity in the open-field test. The
number of mice in B is similar to that in A; the number of mice inD is similar to that in C; the number of mice in F, G is similar to that inH. The colors of the graphs and bar graphs correspond to the
indicated genotypes (top/right). Two-way repeated-measures ANOVA (genotype and time) followed by Holm-Sidak post hoc for multiple-comparisons test was used to analyze the data in C and
F–G. One-way ANOVA followed by Holm-Sidak post hoc formultiple-comparisons test was used to determine differences between indicated groups inH–K. Error bars indicatemean SEM. *p
0.05, significant differences betweenMecp2loxJ/y/NG2Cremouse comparedwith other control littermates (WT,Mecp2loxJ/y,NG2Cre) in C; between the first and the third trial in F,G; and between the
indicated mouse groups in H–K.
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expression in oligodendrocyte lineage cells on the RTT-like
phenotype in heterozygous female mice. To this end,
Mecp2Stop//NG2Cre female mice and their control WT,
NG2Cre, andMecp2Stop / littermate femalemiceweremonitored
biweekly for their body weight and overt RTT-like symptoms.
Like the Mecp2Stop/y/NG2Cre males, the Mecp2Stop//NG2Cre
females showed similar aggregate symptom scores to the
Mecp2Stop/ females (Fig. 5E). Although a trend of improvement
in aggregate symptom scores was noticeable in Mecp2Stop//
NG2Cre female mice, it was statistically nonsignificant (Fig. 5E).
However, as in Mecp2Stop/y/NG2Cre male mice, a significantly
lower percentage ofMecp2Stop//NG2Cre females (20%) devel-
oped the hindlimb clasping phenotype compared with the
Mecp2Stop/ mice (40%) (Fig. 5F). Consistent with previous
studies (Guy et al., 2007), our data show that, after a normal
period of development, female Mecp2Stop / mice became obese
starting at26weeks of age; and by 38weeks of age, theyweighed
20% more than the WT or NG2Cre control female littermates
(Fig. 5G). The weight gain coincides with the initiation of symp-
toms in the Mecp2Stop/ female mice, reaching a plateau corre-
sponding to an aggregate score of 4 beginning at 36 weeks of age
(Fig. 5E). Interestingly, whereas the underweight phenotype of
theMecp2Stop/y male mice was fully rescued by restoring MeCP2
in oligodendrocyte lineage cells in the Mecp2Stop/y/NG2Cre mice
(Fig. 5D), the overweight phenotype observed in Mecp2Stop/
mice, which is typical for female RTTmice (Guy et al., 2007), was
not rescued in theMecp2Stop//NG2Cre female mice (Fig. 5G).
Restoration of MeCP2 in
oligodendrocyte lineage cells
significantly improves specific RTT-like
behavioral deficits in male and female
RTTmice
Mice deficient for MeCP2 demonstrate
motor activity, grip strength, and anxiety
defaults (Guy et al., 2001; McGill et al.,
2006; Santos et al., 2007; Stearns et al.,
2007). We examined whether some of the
behavioral deficits of MeCP2-null mice
are improved in the Mecp2Stop/NG2Cre
mice. We subjected the male Mecp2Stop/y/
NG2Cre mice and their control litter-
mates for behavioral tests at 9–10 weeks
of age, a stage when the Mecp2Stop/y and
Mecp2Stop/y/NG2Cre mice were not se-
verely symptomatic, reaching a median
score of 5–6 (Fig. 5A). As expected, the
motor coordination and forelimb
strength of theMecp2Stop/ymalemice were
significantly impaired as they fell off faster
than their WT and NG2Cre control male
littermates in the rotarod and wire hang
tests (Fig. 6A,C). Interestingly, the
Mecp2Stop/y/NG2Cre mice performed sig-
nificantly better than theMecp2Stop/ymice
and stayed two times longer at trials 2 and
3 in thewire hang test (Fig. 6C). Indeed, in
trail 2, there were no statistical significant
differences between their performance
and the performance of the WT and
NG2Cremale littermates. There was also a
trend of improvement in the performance
of Mecp2Stop/y/NG2Cre mice compared
withMecp2Stop/y mice in the rotarod test, although it was statisti-
cally nonsignificant (Fig. 6A). Similar strength improvements
were noticeable in the digiscan monitoring experiment; whereas
theMecp2Stop/y supported vertical activity was only30% of the
WT and NG2Cre littermate activity, the Mecp2Stop/y/NG2Cre
mice improved up to 65% of the activity level of the WT and
NG2Cremale mice (Fig. 6E), indicating a significant restoration
of the hindlimb strength. In the digiscan tests,Mecp2Stop/y showed
a dramatic decrease in motor activity, reaching only 35% of their
control littermate activity (Fig. 6G). Importantly, the motor ac-
tivity ofMecp2Stop/y/NG2Cremice was improved up to70% of
the activity level of the control WT and NG2Cremale mice (Fig.
6G). Furthermore, motor activity enhancement was also ob-
served in the light/dark box experiments in which the number of
total transitions between the dark and light compartments of the
Mecp2Stop/y/NG2Cremicewas fully restored to the level of theWT
and NG2Cre control male mice, whereas the number of transi-
tions ofMecp2Stop/ymicewas only40% the level of theWTmale
mice (Fig. 6I ). The total time spent in the light or dark com-
partment and the latency to exit the dark were the same for all
genotypes (data not shown), indicating no differences in the
anxiety-like behavior between these mice.
Next, we evaluated the behavior of the female Mecp2Stop//
NG2Cre mice when they were 12 months old, a stage when their
symptoms stabilized and reached amean score of 4–5 (Fig. 5E). Like
themaleMecp2Stop/y/NG2Cremice,we found that themotor activity
of the female Mecp2Stop//NG2Cre mice measured in the digiscan
test was improved up to 90%of the activity levels ofWT orNG2Cre
Figure 3. The expression of MeCP2 is reduced in Mecp2loxJ/y mouse brain compared with that of the WT mouse brain. A,
Quantitative Western blot showing a decrease in the levels of MeCP2 in the indicated brain areas ofMecp2loxJ/y mice versus
control WT mice at 32 weeks of age. Actin served as loading control. B, Representative images of immunostaining of cortex
(top) and hippocampus (bottom) areas of Mecp2loxJ/y and control WT mice immunolabeled for MeCP2 (green). DAPI (blue)
represents nuclear staining. so, Stratum oriens; py, pyramidal layer; sr, stratum radiatum. Scale bars: bottom and left top
panels, 100m; right top panel, 50m.
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femalemice, whereas the activity ofMecp2Stop/mice was only 60%
of their control littermate femalemice (Fig. 6H). In the rotarod and
wirehang tests, the femaleMecp2Stop/micedemonstrateddeficits in
motor coordination and forelimb strength compared with the con-
trol littermates; however, no improvement was noticeable in these
two parameters for theMecp2Stop//NG2Cremice (Fig. 6B,D). On
the other hand, the supported rearing activity of the Mecp2Stop//
NG2Cremice was restored to90% of the level of the WT control
mice (Fig. 6F), indicating a significant hindlimb strength improve-
ment, which allowed the animals to hold up their body transitorily,
unlike theMecp2Stop/mice (Fig. 6F). It is likely that the underper-
formance of Mecp2Stop//NG2Cre mice in the rotarod and in the
Figure 4. MeCP2 protein is restored specifically in the oligodendrocyte lineage cells in brains ofMecp2Stop/y/NG2Cre mice. A, Representative images of brain sections of Mecp2Stop/y male mice
showing global absence of MeCP2 in all cell types. Sections were coimmunostained with MeCP2 (green) and neuronal marker (NeuN, red) in the dentate gyrus area, MeCP2 with astrocytic (GFAP,
red), andOPCs (NG2, red)markers in the hippocampus, andMeCP2withmature oligodendrocytemarker (CC1, red) in the corpus callosum. DAPI (blue) represents nuclear staining.B, Representative
images of immunostaining of brain sections ofMecp2Stop/y/NG2Cremale mice showing specific expression of MeCP2 in OPCs (NG2) and oligodendrocytes (CC1) but not in S100 or GFAP
astrocytes and NeuN neurons. Cell-specific markers and brain areas are as indicated in A. Scale bars: 20 m. Arrows indicate colocalization or absence of MeCP2 in GFAP, S100, NG2, or
CC1-positive cells.
Table 2. Specificity and recombination efficiency in different areas ofMecp2Stop/y/
NG2Cremouse braina
MeCP2Stop/y/NG2Cre
%MeCP2/NeuN %MeCP2/GFAP %MeCP2/NG2
Cortex 1.9 (1936) 1.6 (321) 81.1 (285)
0.5 (1752) 1.0 (387) 75.6 (245)
Striatum 4.3 (2398) 2.2 (273) 85.6 (401)
%MeCP2/S100 %MeCP2/CC1
Corpus callosum — — 89.7 (871)
Ventral cortex — 11.7 (817) —
aValues in parentheses indicate total number of cells.
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wire hang tests, which require whole-body support and coordina-
tion, is due to their obese phenotype (Fig. 5G). Together, our data
indicate that MeCP2 expression in oligodendrocyte lineage cells in
otherwiseMeCP2-nullbrainameliorates someof thebehavioraldef-
icits observed inmale and female RTTmice.
The expression of proteins involved inmyelinproduction is
altered inMecp2Stop/ymice but is only partially restored in the
Mecp2Stop/y/NG2Cremice
We first examined whether the absence of MeCP2 just in the oli-
godendrocyte lineage cells affects the expression of key proteins in-
volved inmyelin production.We analyzed the protein expression of
themyelin-related genes at postnatal day 16
(P16), a time when myelination is actively
occurring in the forebrain. Quantitative
Westernblot analysis showednodifferences
in the protein expression of CNPase (2,3-
cyclic-nucleotide-3-phosphodiesterase),
MOG (myelin oligodendrocyte glycopro-
tein), MBP, or PLP (myelin proteolipid
protein) between WT, Mecp2loxJ/y, and
Mecp2loxJ/y/NG2Cremice (Fig. 7A).
We then analyzed the expression of
the same proteins in whole-brain ex-
tracts of Mecp2Stop/y/NG2Cre mice at
P16. Western blot analysis showed no
changes in the expression of CNPase
and MOG proteins between the differ-
ent types of mice; however, the expres-
sion of MBP and PLP proteins was
significantly altered in Mecp2Stop/ y mice
compared with WT or NG2Cre mice
(Fig. 7B). Specifically, MBP expression
was decreased to 40%, and the PLP
protein level was increased up to
200% of the level in age-matched WT
and NG2Cre control littermate mice
(Fig. 7B). When we analyzed the expres-
sion of the same proteins in the
Mecp2Stop/y/NG2Cre mouse brains, we
found that, whereas the level of PLP re-
mained aberrant, the level of MBP was
only partially restored to 60% of the
level of the control WT or NG2Cremice
(Fig. 7B). We further analyzed the ex-
pression pattern of MBP at P16 by im-
munostaining and found that there
was reduced expression of MBP in the
corpus callosum and striatum of
Mecp2Stop/y mice compared with WT
mice (Fig. 7C). We also evaluated the
thickness of MBP in the corpus callo-
sum and found a significant reduction
in the Mecp2Stop/y brain compared with
that of the WT littermate mice (Fig.
7D,E); however, there were no significant
differences between the MBP thickness be-
tween Mecp2Stop/y mice and Mecp2Stop/y/
NG2Cre mice (Fig. 7D,E). Together,
these data show that the expression of
MeCP2 in oligodendrocytes in other-
wise MeCP2-null mice had no effect
(PLP) or only mild effect (MBP) on res-
toration of proteins involved in myelination and suggest that
there is likely a non– cell-autonomous effect on the expression
of these proteins in oligodendrocytes.
Discussion
Increasing evidence supports the view that RTT is not exclusively
a neuronal disorder but rather a disease that also involves inter-
actions between neurons and glia. Our recent studies and those of
others indicated that at least two glial types, astrocytes and mi-
croglia, negatively affected neurons in a non–cell-autonomous
fashion and contribute to the disease progression (Ballas et al.,
Figure 5. Expression of MeCP2 in oligodendrocyte lineage cells partially rescues some RTT-like features inMecp2Stop/y/NG2Cre
male andMecp2Stop//NG2Cre femalemice.A–D, Phenotypic scores, percentageof hindlimb clasping, Kaplan–Meier survival, and
bodyweight time course, respectively, ofMecp2Stop/y/NG2Cre and the indicated littermate control malemice.B,D, The number of
mice is similar to that indicated in A. E–G, Phenotypic scores, percentage of hindlimb clasping, and body weight time course,
respectively, ofMecp2Stop//NG2Cre and the indicated littermate control female mice. F, G, The number of mice is similar to the
indicated in E. Male and female symbols were used in the figure to distinguish the sex of each animal’s set. Two-way repeated-
measuresANOVA(genotypeand time) followedbyHolm-Sidakpost hoc formultiple-comparisons testwasused toanalyze thedata
inA,D, E, andG. Error bars indicatemean SEM. #p 0.05, significant differences between the controlsWT,NG2Cremalemice,
andMecp2Stop/y andMecp2Stop/y/NG2Cremalemice in A; between the controls WT, NG2Cre femalemice, and theMecp2Stop/ and
Mecp2Stop//NG2Cre female mice in E, G. *p 0.05, significant differences betweenMecp2Stop/y mice and the WT, NG2Cre, and
Mecp2Stop/y/NG2Cre littermate male mice in D. Statistical calculation could not be performed for the age more than 12 weeks
because of the increase number of mortality in theMecp2Stop/y and theMecp2Stop/y/NG2Cremouse group.
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2009; Maezawa and Jin, 2010; Lioy et al.,
2011; Derecki et al., 2012). Here, we tested
for contributions to RTT of a third type of
glia, oligodendrocytes and their progeni-
tor cells, OPCs. We found that, although
there was some overlap in contributions
of oligodendrocytes and astrocytes to the
initiation of RTT-like symptoms, and in
their ability to rescue RTT phenotypes,
some features were idiosyncratic to the
oligodendrocytic lineage.
Loss of MeCP2 from oligodendrocyte
lineage cells, as in the astrocyte k/o mouse
model, resulted in an overall mild pheno-
type. A unique behaviormediated by loss of
MeCP2 from oligodendrocyte lineage cells,
however, was relatively increased activity,
whichwas similar to theWT level of activity
but elevated compared with the activity of
the floxedMecp2malemice. This is likely an
authentic phenotype because the oligoden-
drocyte lineage k/o mice contain the same
floxed allele as the floxed Mecp2 mice, and
the latter develops a weak RTT-like pheno-
typewith time, includingmild hypoactivity,
resulting fromthehypomorphic allele (Figs.
2 and 3). A certain degree of behavioral def-
icits resulting from hypomorphic allele was
also reported for anotherMecp2-loxmouse
model (Mecp2B. lox/y) (Samaco et al., 2008);
however, the reduced level of MeCP2 and
behavioral deficits in the mouse model
(Mecp2
J. lox/y
) we used in the present studies
were milder. Although enhanced activity as
observed in the oligodendrocyte k/omice is
not one of the classical RTT phenotypes,
Mecp2S421A;S424A knock-in mice, in which
MeCP2 phosphorylation is impaired, have
increased locomotion (Tao et al., 2009).
Furthermore, patients with a C-terminal
mutation (R294X) are hyperactive (Chah-
rour and Zoghbi, 2007; Temudo et al.,
2011).Thus,mutations inMecp2 can lead to
a hyperactivity phenotype, in mice and hu-
mans, perhaps reflecting specific functions
mediated by different domains in MeCP2;
however, further studies are warranted to
fully understand this phenotype.
In the rescue paradigm, although the
mice still died prematurely, several RTT-
like symptoms were significantly im-
proved in bothmale and female RTTmice
by restoration of MeCP2 in oligodendro-
cyte lineage cells. Specifically, motor
skills, including activity, strength, and co-
ordination, were significantly improved.
Thus, all glial types expressing MeCP2
seem able to restore, at least in part, the motor levels of male and
female RTT mice (Lioy et al., 2011; Derecki et al., 2012; Lioy and
Mandel, personal communication; Fig. 6). These results together
suggest that the loss of MeCP2 from the different glial types of
RTT mice and patients likely has additive effects on locomotion
deficits.
Compared with astrocytes and microglia, oligodendrocyte
lineage cells expressing MeCP2 had a relatively milder ability to
prolong lifespan. This differential effect could be the result of the
greater ability of MeCP2-restored astrocytes and microglia over
MeCP2-restored oligodendrocyte lineage cells to reverse breath-
ing defects in the MeCP2-null mice (Lioy et al., 2011; Derecki et
Figure 6. Expression of MeCP2 in oligodendrocyte lineage cells in Mecp2Stop/y/NG2Cre male and Mecp2Stop//NG2Cre female
mice partially rescues some of the RTT behavioral deficits. Male and female mice were subjected to the indicated behavioral tests
at 9–10weeks or 1 year of age, respectively. A, B, Rotarod test for male (A) and female (B) mice. C,D, Wire hang test for male (C)
and femalemice (D). E–H, Vertical supported activity (E, F ) and total activity (G,H ) tests in digiscan activitymonitor. E,G, Males.
F,H, Females. I, Light/dark box test for malemice. The colors of the graphs and bar graphs correspond to the indicated genotypes
in the right bottom corner. Male and female symbols were used in the figure to distinguish the sex of each animal’s set. Two-way
repeated-measures ANOVA (genotype and trial) followed by Holm-Sidak post hoc for multiple-comparisons test was used to
analyze the data in A–D. One-way ANOVA followed by Holm-Sidak post hoc for multiple-comparisons test was used to determine
differences between groups in E–I. Error bars indicate mean  SEM. A–D, *p  0.05, significant differences between the
Mecp2Stop mouse group versus all other groups. **p 0.05, significant differences between the bothMecp2Stop andMecp2Stop/
NG2Cre mouse groups versus the WT and NG2Cre littermate groups. #p 0.05, significant differences between the Mecp2Stop/
NG2Cre mouse group versus the Mecp2Stop littermate group. ##p 0.05, significant differences between the Mecp2Stop mouse
group versus the WT and NG2Cre littermate groups. ###p 0.05, significant differences between the Mecp2Stop/NG2Cre mouse
group versus all other groups. A, C, G, I, The number of mice is similar to that indicated in E. B,D,H, The number of mice is similar
to that indicated in F.
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al., 2012). Although there is not much information on the role of
microglia in respiration, astrocytes in particular have been shown
to play an important role in regulating chemosensitive neurons
(Gourine et al., 2010). In addition, unlike astrocytes (Lioy et al.,
2011), oligodendrocyte lineage cells expressing MeCP2 were un-
able to improve the anxiety-like behavior observed in RTTmice.
Nonetheless, oligodendrocyte rescue mice showed an improve-
ment in the hindlimb clasping phenotype that is a prominent
RTT-like symptom inmice. This improvement was not apparent
in mice withMeCP2-restored astrocytes or microglia (Lioy et al.,
2011; Derecki et al., 2012; and data not shown). Interestingly,
unlike the male mice whose underweight phenotype was fully
restored, the obesity phenotype normally observed in female
RTTmice but not in RTT patients was not rescued by restoration
of MeCP2 in oligodendrocyte lineage cells. Together, the com-
parison of the phenotypes in the MeCP2-deficient and rescued
mice of different glial lineages suggests that, like the different
neuronal subtypes (Chen et al., 2001; Fyffe et al., 2008; Chao et al.,
2010), there is also differential and specific contributions of the
different glia to RTT neuropathology.
The loss of MeCP2 specifically in OPCs and differentiated
oligodendrocytes had no effect on the expression level of several
proteins involved inmyelin formation, a primary function of this
lineage. Interestingly, the MeCP2-null male mice used in this
study did display aberrant expression of at least two abundant
myelin-related proteins in the mammalian CNS; MBP and PLP
(Jahn et al., 2009). Nonetheless, restoration of MeCP2 in oligo-
dendrocyte lineage cells in these mice resulted in only partial
restoration of the MBP level, whereas the level of PLP still re-
mained higher than normal. These results infer that MeCP2 ex-
pression in oligodendrocytes has little effect on the expression of
myelin-related proteins and further suggest that there is likely a
non–cell-autonomous influence on the expression of these genes
fromother cell types in the brain, lackingMeCP2. Such non–cell-
autonomous effects could be mediated by neurons and/or astro-
Figure7. MeCP2expression in theoligodendrocyte lineage cells only partially rescues theaberrant expressionpatternofMBPprotein inRTTmice.A, The loss ofMeCP2only in theoligodendrocyte
lineage does not affect the expression pattern of proteins involved in myelination. Quantitative Western blot analysis showing the expression levels of proteins involved in myelin formation in
whole-brain extracts of P16Mecp2loxJ/y/NG2Cre and the indicated control mice. B, Expression of MeCP2 inMecp2Stop/y/NG2Cremice only partially restored the reduced expression of MBP observed
inMecp2Stop/y mice. Quantitative Western blot analysis showing aberrant expression of MBP and PLP in whole-brain extracts of P16Mecp2Stop/y mice and partial restoration of MBP expression in
Mecp2Stop/y/NG2Cre age-matched littermate mice. C, Reconstruction of MBP confocal images of the corpus callosum (CC) and the striatum (ST) areas of the WT andMecp2Stop/y brains. CTX, Cortex;
LV, lateral ventricle. Scale bars, 200m.D, Highmagnification of theMBP immunostaining in the corpus callosum areas. Arrows indicate the thickness of MBP staining in the corpus callosum area
calculated in E. E, Bar graphs representing the thickness ofMBP staining in the corpus callosumarea of theWT,Mecp2Stop/y, andMecp2Stop/y/NG2Cre brains. An average of threemeasurements along
the corpus callosum for each image was used for the thickness calculation. One-way ANOVA followed by Holm-Sidak post hoc for multiple-comparisons test was used to determine differences
between groups in A, B and E. Error bars indicate mean SEM. *p 0.05. n	 3 mice per genotype.
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cytes, which are known to influence myelination by secretion of
signaling molecules. For example, the leukemia growth factor,
LIF, which promotes myelination bymature oligodendrocytes, is
released by astrocytes in response to ATP liberated from axons
firing action potentials (Stevens et al., 2002). Another example is
the release of glutamate from synaptic vesicles along axons, which
promotes myelin induction by stimulating the formation of
cholesterol-rich signaling domains between oligodendrocytes
and axons, and increasing local synthesis of the major protein in
the myelin sheath, MBP (Wake et al., 2011).
Collectively, our studies provide further support for the idea
that different cell types in the brain contribute differentially to
RTT neuropathology, in a cell-autonomous and non–cell-
autonomous manner, through dynamic interactions among the
different neurons and glia. As such, although ubiquitous removal
or reexpression of MeCP2 can recapitulate or reverse, respec-
tively, the full spectrumof RTT symptoms (Chen et al., 2001; Guy
et al., 2007;McGraw et al., 2011; Cheval et al., 2012;Nguyen et al.,
2012; Robinson et al., 2012), the loss or restoration of MeCP2 in
specific cell types only partially initiates or rescues specific RTT
symptoms.
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